Mark Gajjar is a Cardiology physician affiliated with Seton Medical Center Austin. OpenAlex indexes 32 publications with 378 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1180 Seton Pkwy Ste 450
Kyle, TX 786406178
Telephone
512-504-0860Provider last certified this registry record 26 Oct 2020.
Industry payments
17 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year202536 payments$29,684openpaymentsdata.cms.gov ↗
- Edwards Lifesciences CorporationProgram year202541 payments$16,931openpaymentsdata.cms.gov ↗
- Medtronic, Inc.Program year202521 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
84.2%Statin25.5%Atorvastatin Calcium70%Rosuvastatin Calcium21%Pravastatin Sodium8%Simvastatin2%Part D<11 patientsBeta blocker15.1%Metoprolol Succinate48%Carvedilol34%Metoprolol Tartrate17%Part D≥88 patients+ 15 more classes in this area
Blood & clotting
13%Factor Xa inhibitor7.4%Eliquis90%Xarelto10%Part D<11 patientsP2Y12 inhibitor5.6%Clopidogrel76%Prasugrel Hcl24%Part D≥57 patientsMetabolism & gastrointestinal
2.5%Potassium supplement1.4%Potassium Chloride100%Part D≥18 patientsCorticosteroid0.4%Prednisone100%Part D≥11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- TCT-305 The Landmark RESPECT Results Reaffirmed with Real-World Procedural and Safety Outcomes of Patent Foramen Ovale (PFO) Closure Using the AmplatzerTM PFO and AmplatzerTM TalismanTM Occluders
Journal of the American College of Cardiology
2025 - AN OFF-LABEL LIFESAVER: TRANSCATHETER MITRAL VALVE REPAIR FOR SEVERE MITRAL REGURGITATION ASSOCIATED WITH HYPERTROPHIC CARDIOMYOPATHY
Journal of the American College of Cardiology
2022 - JUST ANOTHER BLEEDING HEART: HEYDE'S SYNDROME TREATED WITH TAVR
Journal of the American College of Cardiology
2021
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”